首页 > 市场调查报告书 > 医疗设备

导管消化器

胃肠道支架市场规模、份额和成长分析（按产品、材质、应用、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1898578

胃肠道支架市场规模、份额和成长分析（按产品、材质、应用、最终用户和地区划分）—2026-2033年产业预测

Gastrointestinal Stents Market Size, Share, and Growth Analysis, By Products (Biliary Stents, Duodenal Stents), By Material (Self-Expanding Metal Stents, Nitinol), By Application, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，胃肠道支架市场规模将达到 52.9 亿美元，到 2025 年将达到 55.8 亿美元，到 2033 年将达到 85.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 5.5%。

受胃肠道疾病发病率上升和人口老化的推动，胃肠道支架市场持续稳定成长。生活方式的改变、不健康的饮食习惯以及肥胖率的上升等因素导致结肠癌和发炎性肠道疾病病例的增加。胃肠道疾病的激增推动了对支架的需求，支架是治疗方法改善患者的生活品质。随着人口老化，与老龄化相关的胃肠道疾病，例如狭窄和憩室炎，也变得越来越常见，进一步刺激了市场需求。自膨式金属支架和可生物降解支架等创新技术正在改变治疗效果，而具有防移位功能的新型设计则正在提高支架的长期疗效和患者舒适度。

胃肠道支架市场驱动因素

患者和医疗专业人员对胃肠道支架益处的认识不断提高，有助于胃肠道疾病的早期发现和及时治疗。此外，新兴地区医疗服务可近性的改善也促使支架置入术的使用量激增。这种认知的提高，加上医疗基础设施的改善，使得更多患者寻求有效缓解症状的方法，从而推动了对这些创新医疗设备的需求，并显着促进了胃肠道支架市场的扩张。教育和医疗服务的可近性相结合，在该领域治疗方法的变革中发挥关键作用。

胃肠道支架市场的限制因素

在某些地区，与胃肠道支架手术相关的报销政策可能较为严格，并附加诸多限制条件。这些限制可能会对支架治疗方案的成本效益和可近性产生不利影响。因此，面临经济困难的患者可能不愿意接受此类医疗干预，最终可能阻碍市场扩张。报销不足或手术复杂可能会降低医疗服务提供者推荐或使用这些器械的意愿，导致整体需求下降。因此，这些限制对医疗服务提供者和患者均有影响，并可能对胃肠道支架市场的成长和发展构成重大挑战。

胃肠道支架市场趋势

胃肠道支架市场正显着转向可生物降解支架，这反映出医疗服务提供者和患者越来越倾向于选择能够改善治疗效果的创新解决方案。与传统的金属支架相比，可生物降解支架具有显着优势，主要体现在无需繁琐的取出手术，同时最大限度地减少了与永久植入相关的併发症。这些支架的设计使其能够逐渐溶解，在癒合过程中为患处提供有效支撑，并促进组织自然再生。这一趋势凸显了胃肠道治疗领域以患者为中心的医疗设备发展趋势，即优先考虑安全性、便利性和整体照护品质的提升。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Boston Scientific Corporation（USA）
BD（Becton, Dickinson and Company）（USA）
Cook Medical（USA）
Olympus Corporation（Japan）
Merit Medical Systems（USA）
CONMED Corporation（USA）
ELLA-CS sro（Czech Republic）
Hobbs Medical Inc.（USA）
Taewoong Medical Co. Ltd.（South Korea）
S&G Biotech Inc.（South Korea）
Medtronic（Ireland）
AbbVie（USA）
Johnson & Johnson（USA）
Takeda Pharmaceutical Company Limited（Japan）
Pfizer Inc.（USA）
Novartis AG（Switzerland）
Bayer AG（Germany）
AstraZeneca plc（UK）
Roche Holding AG（Switzerland）
Eli Lilly and Company（USA）

结论与建议

简介目录

Product Code: SQMIG35A2398

Gastrointestinal Stents Market size was valued at USD 5.29 Billion in 2024 and is poised to grow from USD 5.58 Billion in 2025 to USD 8.56 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The gastrointestinal stents market is witnessing consistent growth, fueled by the rising incidence of gastrointestinal disorders and an expanding elderly population. Factors such as lifestyle changes, unhealthy diets, and increasing obesity rates have led to more cases of conditions like colorectal cancer and inflammatory bowel disease. This surge in gastrointestinal issues has increased the demand for stents, known for their effective and minimally invasive treatments that enhance patients' quality of life. As the elderly population grows, age-related gastrointestinal ailments such as strictures and diverticulitis are becoming more common, further driving demand. Innovations like self-expandable metal stents and biodegradable options are transforming treatment outcomes, while new designs with anti-migration features enhance long-term effectiveness and patient comfort in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gastrointestinal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gastrointestinal Stents Market Segments Analysis

Global Gastrointestinal Stents Market is segmented by products, material, application, end users and region. Based on products, the market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal stents. Based on material, the market is segmented into self-expanding metal stents, nitinol, plastic stents and others. Based on application, the market is segmented into biliary diseases, irritable bowel syndrome, gastrointestinal cancers, colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Based on end users, the market is segmented into hospitals and clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Gastrointestinal Stents Market

The increasing awareness of the advantages of gastrointestinal stents among both patients and healthcare professionals has contributed to early detection and prompt treatment of gastrointestinal issues. Additionally, enhanced accessibility to healthcare services in emerging regions has led to a surge in the utilization of stenting procedures. This growing recognition, coupled with improved healthcare infrastructure, has significantly fueled the expansion of the gastrointestinal stents market, as more individuals seek effective solutions for their conditions, thereby driving demand for these innovative medical devices. The combination of education and access is playing a crucial role in transforming treatment approaches in this field.

Restraints in the Gastrointestinal Stents Market

Certain areas experience restrictions in reimbursement policies related to gastrointestinal stent procedures, which may impose rigorous requirements. This limitation can adversely affect the affordability and accessibility of stent-based treatment options. As a result, patients facing financial constraints may be deterred from seeking these medical interventions, ultimately stymying market expansion. When reimbursement is inadequate or difficult to navigate, healthcare providers might hesitate to recommend or utilize these devices, leading to a decrease in overall demand. Consequently, these constraints can present significant challenges for the growth and development of the gastrointestinal stents market, affecting both providers and patients alike.

Market Trends of the Gastrointestinal Stents Market

The gastrointestinal stents market is witnessing a notable shift towards biodegradable options, reflecting a growing preference among healthcare providers and patients for innovative solutions that enhance treatment outcomes. Biodegradable stents present clear benefits over traditional metallic alternatives, primarily by eliminating the need for cumbersome removal procedures while simultaneously minimizing complications related to permanent implants. As these stents are designed to dissolve gradually, they support affected areas effectively during the healing process, allowing for natural tissue regeneration. This trend underscores a broader movement towards patient-centric medical devices that prioritize safety, convenience, and improved overall care in gastrointestinal treatments.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Gastrointestinal Stents Market Size by Products & CAGR (2026-2033)

Market Overview
Biliary Stents
Duodenal Stents
Colonic Stents
Pancreatic Stents
Esophageal Stents

Global Gastrointestinal Stents Market Size by Material & CAGR (2026-2033)

Market Overview
Self-Expanding Metal Stents
Nitinol
Plastic Stents
Others

Global Gastrointestinal Stents Market Size by Application & CAGR (2026-2033)

Market Overview
Biliary Diseases
Irritable Bowel Syndrome
Gastrointestinal Cancers
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Pancreatic Cancer

Global Gastrointestinal Stents Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals And Clinics
Ambulatory Surgical Centers

Global Gastrointestinal Stents Market Size & CAGR (2026-2033)

North America (Products, Material, Application, End Users)
- USA
- Canada
Europe (Products, Material, Application, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Products, Material, Application, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Products, Material, Application, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Products, Material, Application, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ELLA-CS s.r.o. (Czech Republic)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hobbs Medical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taewoong Medical Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
S&G Biotech Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments